Navamedic Welcomes CHMP’s Positive Review of Mysimba’s Cardiovascular Safety

Publisert: 02.04.2025

Navamedic launches Eroxon[®] in Finland

Publisert: 06.11.2024

Navamedic wins joint Nordic antibiotics tender

Publisert: 07.10.2024

Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease

Publisert: 12.09.2024

Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals

Publisert: 16.05.2024

Navamedic welcomes new shareholders

Publisert: 13.03.2024